CR

Charles Raymond

Associate Vice President, Clinical Research at AgNovos Healthcare

Charles Raymond, MBA has a diverse work experience in the healthcare and bioscience industries. Charles is currently serving as the Associate Vice President of Clinical Research at AgNovos Bioscience. Prior to this, they held the position of General Manager and Operating Lead at VJA Associates.

In 2019, Charles worked as the Director of Business Operations at Farcast Biosciences, where they were responsible for managing lab operations, strategic CRO partnerships, and infrastructure and cybersecurity projects. Charles successfully decommissioned and relocated a lab to Mayo Clinic in Jacksonville, Florida.

Before joining Farcast Biosciences, Charles worked at ICON plc from 2015 to 2019. Charles held the role of Director of Business Operations and Strategic Alliances, where they played a crucial role in driving margin expansion and revenue growth for the Medical Devices and Diagnostics business unit. Charles also served as the Commercial Finance Manager, overseeing commercial activities across multiple service lines.

Prior to their tenure at ICON plc, Charles worked as a Senior Business Operations Analyst at PRA Health Sciences, a Senior Financial Analyst at AmerisourceBergen, a Senior Revenue Analyst at CRF Health, and a Senior Finance Associate at BioClinica.

Overall, Charles Raymond brings extensive experience in leadership, operations, finance, and strategic partnerships to their current role as Associate Vice President of Clinical Research at AgNovos Bioscience.

Charles Raymond, MBA received their Bachelor of Science degree in Economics from the University of Scranton in 2005. In 2009, they completed their Master of Business Administration (MBA) with a concentration in Accounting from Saint Joseph's University. In 2013, they obtained a Green Belt certification in Six Sigma from Villanova University.

Links

Previous companies

ICON logo
Farcast Biosciences logo
AmerisourceBergen logo

Timeline

  • Associate Vice President, Clinical Research

    October, 2021 - present